Illingworth Research Group (Illingworth) are delighted to offer clinical monitoring services to accommodate the needs of most clinical trials. Good Clinical Practice (GCP) states a monitor is qualified by their experience, a statement we appreciate and support. Our team has between 3 and 20 years clinical experience across a diverse range of trial phases and therapeutic areas.
We pride ourselves on offering excellent customer service and will endeavour to be adaptable in catering for a study’s needs. Our monitors have experience in a variety of clinical settings in the UK and abroad, alongside in-depth knowledge of many CRF (Case Report Form) systems.
Our ability to offer Monitoring and CRO services alongside our Research Nursing and Medical Photography services means Illingworth is unique, in being able to support your clinical trial fully or in specific areas. This unique working relationship can significantly increase effective communication between clinical departments.
Why Choose Illingworth for your Clinical Monitoring?
Illingworth’s Clinical Research Associates (CRA’s) have experience in all phases of a clinical trial, meaning our CRA’s have monitored in Phase I Units, hospital and GP’s surgery’s depending upon protocol requirements.
Our CRA’s have monitored all over the UK and abroad, this includes: Europe, Africa, America, Australasia and the Far East. Please contact us for further details on our monitoring experience and capabilities globally.
Illingworth’s team of CRA’s have a wealth of experience in many therapeutic areas, these include but not limited too: Respiratory, Oncology, Bioequivalents, Dermatology and Orphan Disease. We also have an excellent knowledge of the Medical Device process and have experience working with combination drug and device trials.
- Site and Investigator Selection
- Pre-study site assessment
- Ethics applications
- Regulatory applications
- Preparation of Investigator meetings
- Initiation meetings
- Monitoring and report writing
- Adverse Event monitoring
- Query resolution
- Investigational Medicinal Product (IMP) accountability
- Preparation for study site audit
- Maintenance of essential documentation
- Close out visits